HRP20030060A2 - 16alpha-methyl or ethyl substituted estrogens - Google Patents

16alpha-methyl or ethyl substituted estrogens Download PDF

Info

Publication number
HRP20030060A2
HRP20030060A2 HR20030060A HRP20030060A HRP20030060A2 HR P20030060 A2 HRP20030060 A2 HR P20030060A2 HR 20030060 A HR20030060 A HR 20030060A HR P20030060 A HRP20030060 A HR P20030060A HR P20030060 A2 HRP20030060 A2 HR P20030060A2
Authority
HR
Croatia
Prior art keywords
compound
treatment
ethyl acetate
compound according
added
Prior art date
Application number
HR20030060A
Other languages
English (en)
Croatian (hr)
Inventor
Jordi Mestres
Hubert Jan Jozef Loozen
Gerrit
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of HRP20030060A2 publication Critical patent/HRP20030060A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HR20030060A 2000-07-28 2001-07-23 16alpha-methyl or ethyl substituted estrogens HRP20030060A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00202697 2000-07-28
PCT/EP2001/008535 WO2002010188A1 (en) 2000-07-28 2001-07-23 16alpha-methyl or ethyl substituted estrogens

Publications (1)

Publication Number Publication Date
HRP20030060A2 true HRP20030060A2 (en) 2004-06-30

Family

ID=8171866

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20030060A HRP20030060A2 (en) 2000-07-28 2001-07-23 16alpha-methyl or ethyl substituted estrogens

Country Status (25)

Country Link
US (2) US7696190B2 (cs)
EP (1) EP1307471B1 (cs)
JP (1) JP2004505093A (cs)
KR (1) KR20030029640A (cs)
CN (1) CN1220696C (cs)
AR (1) AR029989A1 (cs)
AT (1) ATE294812T1 (cs)
AU (2) AU2001282016B2 (cs)
BR (1) BR0112791A (cs)
CA (1) CA2416311C (cs)
CZ (1) CZ2003270A3 (cs)
DE (1) DE60110606T2 (cs)
EC (1) ECSP034448A (cs)
ES (1) ES2241854T3 (cs)
HR (1) HRP20030060A2 (cs)
HU (1) HUP0301592A2 (cs)
IL (2) IL153934A0 (cs)
IS (1) IS6692A (cs)
MX (1) MXPA03000845A (cs)
NO (1) NO20030419L (cs)
PE (1) PE20020331A1 (cs)
PL (1) PL366235A1 (cs)
SK (1) SK882003A3 (cs)
WO (1) WO2002010188A1 (cs)
ZA (1) ZA200300417B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1470151B1 (en) * 2002-01-21 2009-12-30 N.V. Organon Process for the preparation of 7-alpha-methylsteroids
DE10213371C1 (de) * 2002-03-21 2003-12-24 Schering Ag Verfahren zur Herstellung von 7alpha-Methylsteroiden
CN101014610B (zh) * 2004-09-08 2012-08-22 Msd欧斯股份有限公司 具有选择性雌激素活性的15β-取代的类固醇
UA89964C2 (ru) * 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
CN114409717B (zh) * 2021-12-17 2023-03-17 湖南科益新生物医药有限公司 替勃龙中间体醚化物和替勃龙的制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1084261B (de) * 1957-04-11 1960-06-30 Syntex Sa Verfahren zur Herstellung neuer Cyclopentanophenanthrenderivate
NL226738A (cs) * 1957-04-11
US3257429A (en) * 1957-11-12 1966-06-21 Syntex Corp 16-methylene derivatives of estrone and estradiol
US3007946A (en) * 1958-11-06 1961-11-07 Searle & Co 3-alkoxy-16-methylene-1, 3, 5(10)-estratrien-17-ones
US3049555A (en) * 1959-12-22 1962-08-14 Searle & Co 3-alkoxy-16-methyl-1, 3, 5 (10)-estratrien-17-ones
US3092645A (en) * 1961-12-28 1963-06-04 Searle & Co Esters of 17alpha-alkynylester-5(10)-ene-3beta, 17beta-diols
GB1110792A (en) * 1964-04-07 1968-04-24 Res Inst Medicine Chem Novel 5(10)-dehydro-steroids
US3299108A (en) * 1965-10-18 1967-01-17 Searle & Co 17alpha-alkynyl/alkenyl-13beta-alkyl-11-alkylgona-1, 3, 5 (10)-triene-3, 17beta-diols, ethers and esters thereof and intermediates thereto
US3465010A (en) * 1966-11-22 1969-09-02 Searle & Co 17 - (unsaturated hydrocarbon - substituted) 11,13beta - dialkylgon -4 - ene - 3,17beta-diols and esters thereof
US3377366A (en) * 1966-12-02 1968-04-09 Searle & Co 17alpha-alkynyl/alkenyl-11, 13beta-dialkylgon-5(10)-en-3-ones and esters thereof
ZA712312B (en) 1970-04-28 1972-01-26 Ochsner Med Found Alton 4,14-estradiene compounds
US3652606A (en) * 1970-08-07 1972-03-28 Searle & Co 3-oxygenated 11beta-methylestr-4-en-17beta-ol and esters thereof
US3704253A (en) * 1970-09-23 1972-11-28 American Home Prod 13 - polycarbonalkyl - 16 - methylgona-1,3,5(10)-trienes and 13-polycarbonalkyl-16-methylgon - 4 - en-3-ones and intermediates for their production
FR2377419A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides 11b-substitues 1,3,5 (10) trieniques, leur procede de preparation et leur application comme medicament
DE2757157C3 (de) 1977-12-19 1980-10-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von 16 a -alkylierten Steroiden
AU572589B2 (en) 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
US5116830A (en) * 1984-08-17 1992-05-26 Sri International Stereoisomerically pure 17α-ethynyl-estra-2-en-17β-ol and the 17β esters thereof, methods of preparation and uses
DE3822770A1 (de) * 1988-07-01 1990-01-04 Schering Ag 13-alkyl-11ss-phenylgonane
ZA94715B (en) 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints
EP0613687B1 (en) 1993-03-05 1999-06-02 Akzo Nobel N.V. Use of a pregnane derivatives for the treatment of tumours
CA2319765A1 (en) 1998-03-09 1999-09-16 Akzo Nobel Nv New contraceptive kit
TR200003743T2 (tr) * 1998-06-19 2001-07-23 Akzo Nobel N.V. Testosteron türevi.
WO2000031112A1 (en) 1998-11-20 2000-06-02 Akzo Nobel N.V. Estrogenic estra-1,3,5(10)-trienes with differential effects on the alpha and beta estrogen receptors, having a linear hydrocarbon chain of from 5-9 carbon atoms in position 11
TW548277B (en) * 1999-07-16 2003-08-21 Akzo Nobel Nv Orally active androgens
NZ517281A (en) * 1999-09-06 2003-09-26 Akzo Nobel Nv Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11

Also Published As

Publication number Publication date
ES2241854T3 (es) 2005-11-01
IL153934A0 (en) 2003-07-31
WO2002010188A1 (en) 2002-02-07
EP1307471A1 (en) 2003-05-07
ATE294812T1 (de) 2005-05-15
PE20020331A1 (es) 2002-04-30
EP1307471B1 (en) 2005-05-04
SK882003A3 (en) 2003-07-01
AR029989A1 (es) 2003-07-23
US20040043976A1 (en) 2004-03-04
PL366235A1 (en) 2005-01-24
AU2001282016B2 (en) 2005-11-10
US20100029603A1 (en) 2010-02-04
NO20030419D0 (no) 2003-01-27
CN1220696C (zh) 2005-09-28
BR0112791A (pt) 2003-06-24
ECSP034448A (es) 2003-03-10
DE60110606D1 (de) 2005-06-09
CN1444596A (zh) 2003-09-24
MXPA03000845A (es) 2004-04-05
KR20030029640A (ko) 2003-04-14
AU8201601A (en) 2002-02-13
IS6692A (is) 2003-01-20
HUP0301592A2 (hu) 2003-09-29
DE60110606T2 (de) 2005-12-01
CZ2003270A3 (cs) 2003-06-18
CA2416311C (en) 2009-04-28
CA2416311A1 (en) 2002-02-07
IL153934A (en) 2007-07-24
JP2004505093A (ja) 2004-02-19
US7696190B2 (en) 2010-04-13
NO20030419L (no) 2003-01-27
ZA200300417B (en) 2004-04-15

Similar Documents

Publication Publication Date Title
JP5698974B2 (ja) ニューロステロイド化合物
DE60025817T2 (de) Ent-steroide als selektiv wirksame estrogene
EP1272505B1 (de) 8beta-substituierte-11beta-pentyl-und 11beta-hexyl-estra-1,3,5(10)-trienderivate
RU2386637C2 (ru) 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ С ИЗБИРАТЕЛЬНОЙ ЭСТРОГЕННОЙ АКТИВНОСТЬЮ
USRE34136E (en) 9 alpha, 11 beta-substituted and 11 beta-substituted estranes
DE69902684T2 (de) Estrogenische estra-1,3,5(10)-trien verbindungen mit verschiedenen wirkungen auf estrogenrezeptor alpha und beta mit einer unverzweigten kohlenwasserstoffkette von 5-9 kohlenstoffatomen in position 11
US20100029603A1 (en) 16alpha-methyl or ethyl substituted estrogens
US3551459A (en) 13-methyl-8-isogonanes
US6677329B1 (en) Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11
SK139194A3 (en) The improved antiandrogens
DE1593616A1 (de) Verfahren zur Herstellung von Steroidverbindungen
AU2001282016A1 (en) 16alpha-methyl or ethyl substituted estrogens
JP5658748B2 (ja) 女性のヘルスケアにおける使用のための置換型１６，１７−環紋型ステロイド化合物
TW200940562A (en) 17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-one derivative, use thereof and medicinal products containing the derivative
CN101014610A (zh) 具有选择性雌激素活性的15β－取代的类固醇
MX2007002815A (es) Esteroides substituidos pro 15( que tienen actividad.
HK1105296B (en) 15beta-substituted steroids having selective estrogenic activity

Legal Events

Date Code Title Description
ODRP Renewal fee for the maintenance of a patent

Payment date: 20030708

Year of fee payment: 3

A1OB Publication of a patent application
OBST Application withdrawn